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In this issue of the Journal, there are three public health articles that are closely related in their clinical relevance and pertinence 
to the situation in Oman.1,2,3 First, in our Sounding 
Board section, Dr. Prashanth Panduranga et al.1 
writes a provocative article regarding the statistics 
and management of acute coronary syndrome (ACS) 
in Oman using the data from the Gulf Registry of 
Acute Coronary Events (RACE) database. Second, 
in another Sounding Board article, Dr. Alyaarubi 
stimulates us to rethink our strategies for the care 
of the diabetic patient in Oman.2 Third, Dr. Rashid 
Al-Saadi et al. present their original research 
on the prevalence of uncontrolled hypertension 
(HTN) amongst outpatients attending the health 
clinics in one region of Oman.3 The combination 
of poor diabetes control and uncontrolled HTN is 
responsible for a great percentage of the incidence 
of ACS and the accompanying complications, as 
discussed by Dr. Panduranga and his team. These 
two conditions are commonly accompanied by 
other risk factors for ACS, including overweight, 
obesity, metabolic syndrome and hyperlipidaemia. 
These chronic non-communicable diseases, which 
form the bulk of risk factors for coronary heart 
disease, need our attention as physicians and 
medical educators as the public has entrusted us 
with the care of their health.
ACS is basically the clinical syndrome of an 
acute occlusion within what is commonly an already 
diseased coronary artery. This often presents 
as unstable angina and can lead to myocardial 
infarction with or without ST segment elevation. 
Aetiologically, coronary artery disease is closely 
tied to HTN, diabetes mellitus (DM), dyslipidaemia, 
metabolic syndrome and obesity among other 
factors. The two major factors, diabetes and 
HTN, are clearly described in this issue as being 
sub-optimally managed in Oman. In addition, 
obesity and metabolic syndrome are described as 
significant hazards to the health of Omanis. Thus, 
we as physicians have to rethink our strategies 
for the management of coronary artery disease. 
The Ministry of Health (MOH) is the guardian of 
the health of Omanis and hence has to take the 
initiative in novel ways to reduce the prevalence of 
poorly controlled diabetes and uncontrolled HTN 
among its citizens so that we can adequately reduce 
the incidence of ACS and other complications of 
these chronic diseases.
Clearly, we must start by improving management 
of the root causes, especially diabetes and HTN. 
Both are major contributors to the burden of 
chronic non-communicable diseases in Oman and 
throughout the world. Dr. Jawad Al-Lawati et al. 
pointed out that cardiovascular disease is “currently 
the leading cause of death” in Oman.4 They go on 
to explain, “Unless reforms are introduced to the 
current health care system, chronic diseases will 
constitute a major drain on Oman’s human and 
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financial resources” as these diseases form 75% 
of the disease burden in Oman.4 The list includes 
diabetes, HTN, obesity, metabolic syndrome and 
hyperlipidaemia, which are specifically discussed in 
articles in this issue. The implication of such dire a 
situation is that Oman needs to rethink its strategies 
for dealing with this emerging epidemiology. The 
MOH needs to reposition its priorities and give 
increased attention to the management of these 
chronic non-communicable diseases in Oman.  
Management of DM needs special attention 
from the MOH and from physicians in Oman. 
We cannot afford to take this responsibility lightly 
and invest our energy in controlling diabetes and 
these other chronic non-communicable diseases. 
Dr. Alyaarubi points out that the incidence of DM 
is increasing in children who now have an earlier 
and higher incidence of Type 2—a condition 
which is traditionally looked upon as a disease of 
adults. He also alerts us to the fact that in the last 
few years there have been several innovations in 
the management of diabetes including new oral 
hypoglycaemic medication and bioengineered 
(analogue) insulin; newer delivery tools, such as 
insulin pumps, and follow-up tools such as HbA1c, 
as well as internationally recommended guidelines. 
Unfortunately we, in Oman, have not capitalised 
on these innovations.2 There is however, a great 
need for us to keep up with these developments. 
DM cannot be adequately managed either by a 
typical family practitioner who is overworked and 
inadequately equipped for proper diabetes care, or 
by a typical general internist for that matter. 
There need to be specialised Diabetes Care 
Clinics—at least two in the capital area and one in 
each region. More doctors need to be sent abroad 
to major diabetic centres in the world to specialise 
and become expert diabetologists. Oman needs to 
train nurses to become diabetes educators, social 
workers and therapists in the complications and 
care of DM, and train or hire podiatrists. Every 
diabetic clinic should have a resident nutritionist 
and for other primary care clinics there should be 
at least a visiting nutritionist, perhaps one day in 
each primary care clinic. Nutritionists are needed 
not only for counselling diabetics about their 
diet, but also to manage overweight, obesity and 
hyperlipidaemia, all of which are major problems in 
Oman as in most countries.4 
We need formal and informal classes to educate 
patients about their disease, to train them to test 
their own urine and blood, and to understand the 
importance of good diabetes control, the meaning 
of the various laboratory results and the potential 
complications.2
Our government will have to invest more 
in the care of diabetes and other chronic non-
communicable diseases. We need to take 
seriously into consideration what Dr. Alyaarubi 
has conveyed in this issue. We have to pay more 
attention to diabetes because it is a killer. It is a 
major cause of cardiovascular disease, known 
since the Framingham study,5 and now shown to 
be the case in Oman.1 Other workers have shown 
that DM not only leads to coronary heart disease, 
but also “Diabetic patients with acute coronary 
syndromes had worse 30-day and 6-month 
outcomes, particularly those without ST segment 
elevation”.6 Statistically, the incidence of myocardial 
infarction in diabetics is as high as in patients who 
have had a previous infarction.7 There are several 
other publications pointing to diabetes and HTN as 
major factors leading to coronary heart disease.8-11 
The risk factors for coronary heart disease were 
well established by the turn of the century.9-11 Thus, 
the importance of these three major chronic non-
communicable diseases and their interrelationship 
has to be tackled with determination, dedication 
and passion. The MOH needs to invest a significant 
portion of its finance and manpower in these 
diseases as well as other chronic non-infectious 
diseases, including obesity, metabolic syndrome 
and hyperlipidaemia all of which contribute to the 
high mortality and morbidity accompanying ACS. 
Oman can succeed in this effort as it has a history 
of previous public health successes such as the 
vaccination of the paediatric population and the 
eradication of polio and other serious childhood 
maladies for which it has been commended by the 
World Health Organization. 
Dr. Al-Saadi et al.'s article reveals that not only is 
diabetes poorly controlled among patients at Oman 
primary care health centres (PHC), but that we also 
have a major problem with HTN control. Only 39% 
of patients attending the PHC in Seeb (a district in 
the Muscat capital area) have their blood pressure 
(BP) under control as per the criteria described in 
the 7th Report of the Joint National Committee on 
Prevention Detection Evaluation & Treatment of 
High Blood Pressure (JNC-7).2,12 This is a situation 
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that can be significantly improved by modifying 
health care delivery in Oman—through action 
by both doctors and the government. In fact, the 
situation is worse than the overall 61% uncontrolled 
BP—“74% of the total subjects were overweight 
(27%) or obese (47%). Of those who were obese, 
69% failed to achieve their BP targets”.3 If Barbados 
can achieve 58% control of HTN and some Veterans 
Administration Hospitals in USA can achieve nearly 
70%, then why not Oman? We have managed to 
surpass many Western countries in our vaccination 
rate13 so likewise we should be able to do the same 
with the BP control rate. An inadequate control 
rate of 61%, will almost certainly contribute to the 
incidence of ACS and its complications. When 
inadequate BP control is combined with diabetes, 
then we are treading on dangerous territory. 
The management of HTN must be carried out 
by well-trained physicians and specially trained 
staff. This should be carried out at specialised 
clinics, or at least where there is adequate support 
from other health care workers. We need to send 
doctors to train specifically in the management of 
HTN and its complications. Each newly diagnosed 
case of HTN needs to be thoroughly investigated 
by specially trained personnel to rule out secondary 
causes. These are well outlined in the JNC-7 
report.12 The management of HTN has to follow 
either these guidelines or other internationally 
recognised evidence-based guidelines. Physicians 
need to change their attitude and behaviour. For 
example JNC-7 recommends thiazides for stage I 
HTN (140–159 systole or 90–99 diastole), and to 
use a two drug combination for Stage 2 HTN (>160 
or >100), as well as to use educators to help patients 
lose weight since BP can fall 5–20 mmHg per 10 kg 
of weight loss.12 They also recommend adopting the 
DASH (Dietary Approaches to Stop Hypertension) 
eating plan (fruit vegetables, low fat, low salt and 
exercise to achieve a 2–14 mmHg BP drop) while 
intensive lifestyle modification should be pursued in 
all individuals with metabolic syndrome. This is just 
an example from the simplified guidelines for family 
practioners.12 More complex guidelines are available 
for specialty centres from the same reference. 
However, it is clear that we need specialised 
personnel in order to improve our statistics for 
controlled HTN in Oman. Co-morbidities are 
common in HTN, including overweight and obesity, 
metabolic syndrome, hyperlipidaemia and diabetes; 
these, singly or collectively, lead to ACS. Oman 
needs to invest in training health care providers, 
not only by sending more physicians abroad (to 
become cardiologists, endocrinologists, lipid 
specialists), but also by training patient educators, 
dieticians/nutritionists, therapists, social workers, 
and establishing patient-centred behavioural 
interventions such as counselling. Patients have 
to understand BP goals, weight targets and the 
potential complications as well as the importance 
of compliance.12  
The two papers discussed above2,3 are disturbing 
to many of us who were not aware that these two 
major health hazards, HTN and diabetes, are 
not adequately taken care of in the PHCs of our 
country. These two are major contributors to ACS, 
the subject of another paper in this issue by Dr. 
Panduranga and his colleagues.1 In their analysis 
of the Gulf RACE database they have uncovered 
that among the Omani patients with ACS, we 
have a higher prevalence of diabetes mellitus, 
heart failure and unstable angina, and that there 
are also problems with management of ACS and 
its complications in Oman.1 Thus we do indeed 
have a problem in Oman with respect to how we 
deal with not only the chronic non-communicable 
diseases such as HTN and diabetes, but also their 
consequence coronary heart disease. Among 
the steps that can be taken immediately to cope 
with the high incidence of ACS is, first, to send 
more doctors abroad to study different aspects of 
cardiology such as interventional cardiology, then 
to set up more emergency centres able to cope with 
cardiac emergencies and train doctors to be more 
aggressive in their treatment not only of young 
patients, or those in good condition who are low 
risk patients, but also of those patients who are 
considered intermediate or high risk and are being 
currently avoided by most cardiologists in Oman.1 
Dr. Panduranga et al. suggest that this contributes 
to the dismally low national percentage (11%) 
of the utilisation of cardiac catheterisation and 
angiography.1 This is further complicated by the fact 
that the whole of Oman with its c. 3,000,000 citizens 
has only two cardiac catheterisation facilities. This 
is despite the fact, established in the literature, that 
primary catheterisation is of significant benefit in 
ACS: “primary percutaneous coronary intervention 
(PCI), compared with fibrinolysis, will save lives, 
enhance myocardial recovery, prevent intracranial 
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bleeding, stroke, reinfarction, and recurrent 
ischaemia, and otherwise enhance cardiovascular 
outcomes”.14 The tremendous progress in survival 
and reduced morbidity in the last several years has 
been attributed to the use of coronary care units 
and reperfusion efforts. Fibrinolysis saves lives, but 
early PCI in patients with ST elevation myocardial 
infarction (STEMI) can double the benefit.14 This 
reperfusion effort needs a catheter laboratory and 
Oman needs more of these. This effort also needs 
well-trained doctors and these are also in short 
supply here. It also needs a good quality assurance 
programme with physicians who are willing to 
treat more aggressively as primary PCI saves lives 
and can reduce complications including with 
better myocardial recovery.14,15 Urgent diagnostic 
catheterisation is now also recommended for non-
STEMI. “Primary PCI” is also superior to “Rescue 
PCI” after failed thrombolysis.16 Thus, with only two 
cardiac catheterisation centres in the country, the 
concern is genuine and needs to be taken seriously 
by the health authorities. Likewise the concern that 
physicians in Oman are not following international 
recommended guidelines for management of ACS 
also needs tackling.1 These guidelines are evidence-
based17 and we should either adhere to them, or to 
other evidence-based guidelines that are accepted 
internationally. Another concern in the care of 
coronary heart disease in Oman is the lack of 
positron emission tomography (PET) scanners, 
an important tool not only in the early diagnosis 
of coronary heart disease, but also in the non-
interventional diagnosis of myocardial viability.  
SQUMJ hereby extends an open invitation to 
scholars and researchers in Oman to write about 
the other major chronic non-communicable 
diseases in Oman particularly those that contribute 
to, or directly lead to coronary heart disease and 
ACS. Are these diseases managed optimally or not? 
If not, how bad is the situation and how can it be 
improved? We doctors, and the other allied health 
care providers of Oman, need to help the MOH 
in improving the health of our citizens. The MOH 
cannot do it alone, but it does need to take the 
initiative and the bulk of the responsibility.  
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